Injectional anthrax - New presentation of an old disease

Eurosurveillance

Volumn 19, Issue 32, 2014, Pages

  Berger, T ^a,b   Kassirer, M ^a   Aran, A A ^a,c  

^a MEDICAL CORPS   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DEXAMETHASONE; DIAMORPHINE; DICLOXACILLIN; FLUCLOXACILLIN; GENTAMICIN; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; VANCOMYCIN;

ABDOMINAL PAIN; ALCOHOL ABUSE; ANTHRAX; ANTIBIOTIC THERAPY; AWARENESS; BACILLUS ANTHRACIS; BACTEREMIA; BLOOD CLOTTING DISORDER; CEREBROSPINAL FLUID ANALYSIS; DEBRIDEMENT; DISEASE COURSE; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; ERYTHEMA; EUROPE; FATALITY; FEVER; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KNOWLEDGE BASE; LITERATURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE ORGAN FAILURE; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SEPSIS; SKIN GRAFT; SKIN INFECTION; SKIN NECROSIS; SMOKING; TOXEMIA;

EID: 84908701079     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.32.20877     Document Type: Review

References (36)

1. Martin GJ, Friedlander AM. Bacillus anthracis (Anthrax). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Philadelphia: Elsevier Inc. 2010. Chapter 208. p. 2715–2725. http://dx.doi.org/10.1016/B978-0-443-06839-3.00208-3
2. Purcell BK, Worsham PL, Friedlander AM. Anthrax. In: Dembek ZF, editor. Medical Aspects of Biological Warfare. Washington, DC: Office of the Surgeon General, US Army Medical Department Center and School; Borden Institute, Walter Reed Army Medical Center; 2007. p. 69–90.
3. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. Stockholm: ECDC; 2011. Available from: http://www.ecdc.europa.eu/en/publications/publications/1111_sur_annual_epidemiological_report_on_communicable_diseases_in_europe.pdf
4. Ringertz SH, Høiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, et al. Injectional anthrax in a heroin skin-popper. Lancet. 2000; 356(9241):1574–5. http://dx.doi.org/10.1016/S0140-6736(00)03133-0
5. Ramsay CN, Stirling A, Smith J, Hawkins G, Brooks T, Hood J, et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill. 2010;15(2): pii= 19465.
6. Radun D, Bernard H, Altmann M, Schöneberg I, Bochat V, van Treeck U, et al. Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009. Euro Surveill. 2010;15(2):pii=19464.
7. Christie B. Heroin contaminated with anthrax has killed 11 people. BMJ. 2010;340:c937.http://dx.doi.org/10.1136/bmj.c937
8. Health Protection Scotland (HPS). National Anthrax Outbreak Control Team: An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. Glasgow: HPS; 2011.
9. Public Health England website - Health Protection topics – Anthrax: Information on 2012 outbreak. [Accessed 26 January 2014]. Available from: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Anthrax/
10. ProMED-mail. [Accessed 26 Jan2014]. Available from: http://www.promedmail.org/
11. European Centre for Disease Prevention and Control (ECDC). [Accessed 26 Jan 2014]. Available from: http://www.ecdc.europa.eu/en/Pages/home.aspx
12. Palmateer NE, Ramsay CN, Browning L, Goldberg DJ, Hutchinson SJ. Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis. 2012;55(5):706–10. http://dx.doi.org/10.1093/cid/cis511
13. Price EP, Seymour ML, Sarovich DS, Latham J, Wolken SR, Mason J, et al. Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe. Emerg Infect Dis. 2012;18(8):1307–13. http://dx.doi.org/10.3201/eid1808.111343
14. Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, et al. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill. 2012;17(26): pii=20204
15. Grunow R, Verbeek L, Jacob D, Holzmann T, Birkenfeld G, Wiens D, et al. Injection anthrax-a new outbreak in heroin users. Dtsch Arztebl Int. 2012;109(49):843–8.
16. Beaumont G. Anthrax in a Scottish intravenous drug user. J Forensic Leg Med. 2010;17(8):443–5. http://dx.doi.org/10.1016/j.jflm.2010.09.008
17. Parcell BJ, Wilmshurst AD, France AJ, Motta L, Brooks T, Olver WJ. Injection anthrax causing compartment syndrome and necrotising fasciitis. J Clin Pathol. 2011;64(1):95–6. http://dx.doi.org/10.1136/jcp.2010.082586
18. Powell AG, Crozier JE, Hodgson H, Galloway DJ. A case of septicaemic anthrax in an intravenous drug user. BMC Infect Dis. 2011;11:21. http://dx.doi.org/10.1186/1471-2334-11-21
19. Jallali N, Hettiaratchy S, Gordon AC, Jain A. The surgical management of injectional anthrax. J Plast Reconstr Aesthet Surg. 2011 Feb; 64(2):276–7. http://dx.doi.org/10.1016/j.bjps.2010.06.003
20. Knox D, Murray G, Millar M, Hamilton D, Connor M, Ferdinand RD, et al. Subcutaneous anthrax in three intravenous drug users. J Bone Joint Surg Br. 2011;93(3):414–7. http://dx.doi.org/10.1302/0301-620X.93B3.25976
21. Johns N, Cooper D, Terrace J. An unusual case of peritonitis in an intravenous drug user. Gastroenterology. 2011;141(2):435–6, 780–1. http://dx.doi.org/10.1053/j.gastro.2011.02.076
22. Meghji S, Judd O, Carr E. Fatal cutaneous anthrax in a heroin user. J Laryngol Otol. 2013;127(4):423-5. http://dx.doi.org/10.1017/S0022215112003210
23. Bannard-Smith J, Carroll I, Nichani R, Sharma R. Anthrax infection in an intravenous drug user. Intensive Care Med. 2013;39(3):530. http://dx.doi.org/10.1007/s00134-012-2772-0
24. Booth MG, Hood J, Brooks TJ, Hart A. Anthrax infection in drug users. Lancet 2011;375(9723):1345–1346. http://dx.doi.org/10.1016/S0140-6736(10)60573-9
25. Russell L, Pedersen M, Jensen AV, Sřes LM, Hansen AB. Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users. BMC Infect Dis. 2013;13:408. http://dx.doi.org/10.1186/1471-2334- 13-408
26. European Centre for Disease Prevention and Control (ECDC). Risk assessment: Anthrax cases among injecting drug users Germany, June-July 2012 - Update, 13 July 2012. [Accessed 6 Feb 2013]. Available from: http://ecdc.europa.eu/en/publications/publications/rapid-risk-assessent-anthrax-idus-july-13.pdf
27. Grunow R, Klee SR, Beyer W, George M, Grunow D, Barduhn A, et al. Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000. Euro Surveill. 2013 Mar 28;18(13): pii=20437
28. Rückert C, Licht K, Kalinowski J, Espírito Santo C, Antwerpen M, Hanczaruk M et al. Draft genome sequence of Bacillus anthracis UR-1, isolated from a German heroin user. J Bacteriol. 2012;194(21):5997-8. http://dx.doi.org/10.1128/JB.01410-12
29. Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT et al. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20(2). http://dx.doi.org/10.3201/eid2002.130687
30. Kaushik KS, Kapila K, Praharaj AK. Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol. 2011;60 (Pt 4):408–22. http://dx.doi.org/10.1099/jmm.0.027540-0
31. Lavender TW, McCarron B. Acute infections in intravenous drug users. Clin Med. 2013;13(5):511-3. http://dx.doi.org/10.7861/clinmedicine.13-5-511
32. Hope VD, Palmateer N, Wiessing L, Marongiu A, White J, Ncube F et al. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. Am J Public Health. 2012;102(1):122-5. http://dx.doi.org/10.2105/AJPH.2011.300314
33. McGuigan CC, Penrice GM, Gruer L, Ahmed S, Goldberg D, Black M et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottishinjecting drug users. J Med Microbiol. 2002;51(11):971-7.
34. Palmateer NE, Hope VD, Roy K, Marongiu A, White JM, Grant KA et al. Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis. 2013;19 (1):29-34. http://dx.doi.org/10.3201/eid1901.120044
35. Stern EJ, Uhde KB, Shadomy SV, Messonnier N. Conference Report on Public Health and Clinical Guidelines for Anthrax. Emerg Infect Dis. 2008;14(4). http://dx.doi.org/10.3201/eid1404.070969
36. Health Protection Scotland (HPS). Interim clinical guidance for the management of suspected anthrax in drug users: version 12.1. [Accessed 5 Feb, 2013]. Available from: http://www.hps.scot.nhs.uk/anthrax/documents/clinical-guidance-for-use-of-anthraximmune-globulin-v12-1-2010-03-19.pdf